ViVerita Therapeutics Announces Research Collaboration with Boehringer Ingelheim to Accelerate Discovery of Novel Cancer Targets

ViVerita Therapeutics today announced a strategic research collaboration with Boehringer Ingelheim aimed at accelerating the discovery and validation of novel therapeutic targets. Under the terms of this collaboration, ViVerita will leverage its industry-leading in vivo CRISPR-based discovery platform to evaluate a curated set of putative targets identified by Boehringer Ingelheim, assessing their functions under physiologically relevant conditions.

https://www.prnewswire.com/news-releases/viverita-therapeutics-announces-research-collaboration-with-boehringer-ingelheim-to-accelerate-discovery-of-novel-cancer-targets-302447389.html?tc=eml_cleartime